Michael Marcus Hoffmann
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Sirtuins and Resveratrol in Medicine 3
- Surgery 9
- Lipoproteins and Cardiovascular Health 8
- Co-authors
- Winfried März (16 shared papers)Bernhard Otto Boehm (7 shared papers)Bernhard Rudolf Winkelmann (7 shared papers)Klaus Langer (1 shared paper)Karl Michaelis (1 shared paper)J. Kreuter (1 shared paper)Renad Nikolaevich Alyautdin (1 shared paper)Martin Michaelis (1 shared paper)
- Journals
- European Heart Journal (6 papers)Atherosclerosis (5 papers)European Journal of Clinical Investigation (2 papers)Diabetologia (2 papers)Obstetrics and Gynecology (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Marcus Hoffmann
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Drug Discovery 1
- Biomaterials 149
- Surgery 227
- Nephrology 47
- Neurology 30
Countries citing papers authored by Michael Marcus Hoffmann
This map shows the geographic impact of Michael Marcus Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Marcus Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Marcus Hoffmann more than expected).
Fields of papers citing papers by Michael Marcus Hoffmann
This network shows the impact of papers produced by Michael Marcus Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Marcus Hoffmann. The network helps show where Michael Marcus Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Marcus Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 301 | |
| 2 | 2004 | 101 | |
| 3 | 2005 | 86 | |
| 4 | 2010 | 81 | |
| 5 | 2004 | 76 | |
| 6 | 2005 | 70 | |
| 7 | Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500-->Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405-->Gln) diminishes receptor-mediated uptake of LDL. | 1999 | 49 |
| 8 | 2003 | 47 | |
| 9 | 2011 | 45 | |
| 10 | 2002 | 42 | |
| 11 | 2008 | 35 | |
| 12 | 2003 | 29 | |
| 13 | 2008 | 28 | |
| 14 | 2009 | 24 | |
| 15 | 2004 | 23 | |
| 16 | 1999 | 18 | |
| 17 | 2000 | 17 | |
| 18 | 2009 | 16 | |
| 19 | 2001 | 15 | |
| 20 | 2002 | 12 |
About Michael Marcus Hoffmann
Michael Marcus Hoffmann is a scholar working on Geriatrics and Gerontology, Surgery, Physiology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Lipid metabolism and disorders (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Alzheimer's disease research and treatments (2 papers), Folate and B Vitamins Research (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Biomaterials (149 citations), Surgery (227 citations), Nephrology (47 citations) and Neurology (30 citations). Michael Marcus Hoffmann has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Winfried März, Bernhard Otto Boehm, Bernhard Rudolf Winkelmann, Klaus Langer, Karl Michaelis, J. Kreuter, Renad Nikolaevich Alyautdin, Martin Michaelis, Hubert Scharnagl and K. Elise Winkler. Their work appears in journals such as European Heart Journal, Atherosclerosis, European Journal of Clinical Investigation, Diabetologia and Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.